Transcatheter valve implantation for aortic and tricuspid valve regurgitation: A case report_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

XIAO Bowen , LIU Lulu , WU Binggang , SHI Jun ,  GUO Yingqiang

Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China;

Corresponding author：

GUO Yingqiang, Email: drguoyq@wchscu.cn

Keywords：

Aortic valve regurgitation; transcatheter aortic valve implantation; transcatheter tricuspid valve implantation; tricuspid regurgitation; case report

DOI：

10.7507/1007-4848.202402001

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Transcatheter aortic valve implantation (TAVI) is an important alternative in treating high-risk patients with aortic valve regurgitation. Transcatheter tricuspid valve implantation (TTVI) is also an important treatment option for high-risk patients with tricuspid regurgitation. We reported a 72-year male patient who underwent TAVI due to severe aortic valve regurgitation using a J-Valve. During a two-year follow-up, the patient developed secondary tricuspid regurgitation to atrial fibrillation, and subsequently received TTVI using a LuX-Valve. Following the interventions, the patient's symptoms were significantly improved, and echocardiography indicated good hemodynamic performance of both transcatheter heart valves. This case highlights the feasibility and effectiveness of performing multiple valve implantations via transcatheter approaches in high-risk elderly patients.

Citation： XIAO Bowen, LIU Lulu, WU Binggang, SHI Jun, GUO Yingqiang. Transcatheter valve implantation for aortic and tricuspid valve regurgitation: A case report. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2024, 31(6): 929-932. doi: 10.7507/1007-4848.202402001 Copy

1.	Topilsky Y, Khanna A, Le Tourneau T, et al. Clinical context and mechanism of functional tricuspid regurgitation in patients with and without pulmonary hypertension. Circ Cardiovasc Imaging, 2012, 5(3): 314-323.
2.	Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 2021, 143(5): e72-e227.
3.	Guta AC, Badano LP, Tomaselli M, et al. The pathophysiological link between right atrial remodeling and functional tricuspid regurgitation in patients with atrial fibrillation: A three-dimensional echocardiography study. J Am Soc Echocardiogr, 2021, 34(6): 585-594.
4.	Kazum S, Vaturi M, Yedidya I, et al. Progression of non-significant mitral and tricuspid regurgitation after surgical aortic valve replacement for aortic regurgitation. J Clin Med, 2023, 12(19): 6280.
5.	Offen S, Playford D, Strange G, et al. Adverse prognostic impact of even mild or moderate tricuspid regurgitation: Insights from the national echocardiography database of australia. J Am Soc Echocardiogr, 2022, 35(8): 810-817.
6.	Cuko B, Baudo M, Ternacle J, et al. One-stage transcatheter aortic valve implantation and transcatheter edge-to-edge tricuspid valve repair for double valve dysfunction in a high-risk patient. Cureus, 2023, 15(9): e45648.
7.	Salido Tahoces L, Sánchez Recalde A, Fernández-Golfín C, et al. Concomitant percutaneous treatment of aortic stenosis and tricuspid regurgitation. Eur Heart J Cardiovasc Imaging, 2022, 23(6): e262.
8.	Taramasso M, Alessandrini H, Latib A, et al. Outcomes after current transcatheter tricuspid valve intervention: Mid-term results from the International TriValve Registry. JACC Cardiovasc Interv, 2019, 12(2): 155-165.
9.	Hahn RT, Kodali S, Fam N, et al. Early multinational experience of transcatheter tricuspid valve replacement for treating severe tricuspid regurgitation. JACC Cardiovasc Interv, 2020, 13(21): 2482-2493.
10.	Mahowald MK, Nishimura RA, Pislaru SV, et al. Reduction in right atrial pressures is associated with hemodynamic improvements after transcatheter edge-to-edge repair of the tricuspid valve. Circ Cardiovasc Interv, 2021, 14(12): e010557.
11.	陈思, 顾君君, 杨帆, 等. LuX-Valve系统经导管三尖瓣置换26例近期疗效分析. 中国心血管病研究, 2022, 20(2): 104-107.

1. Topilsky Y, Khanna A, Le Tourneau T, et al. Clinical context and mechanism of functional tricuspid regurgitation in patients with and without pulmonary hypertension. Circ Cardiovasc Imaging, 2012, 5(3): 314-323.
2. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 2021, 143(5): e72-e227.
3. Guta AC, Badano LP, Tomaselli M, et al. The pathophysiological link between right atrial remodeling and functional tricuspid regurgitation in patients with atrial fibrillation: A three-dimensional echocardiography study. J Am Soc Echocardiogr, 2021, 34(6): 585-594.
4. Kazum S, Vaturi M, Yedidya I, et al. Progression of non-significant mitral and tricuspid regurgitation after surgical aortic valve replacement for aortic regurgitation. J Clin Med, 2023, 12(19): 6280.
5. Offen S, Playford D, Strange G, et al. Adverse prognostic impact of even mild or moderate tricuspid regurgitation: Insights from the national echocardiography database of australia. J Am Soc Echocardiogr, 2022, 35(8): 810-817.
6. Cuko B, Baudo M, Ternacle J, et al. One-stage transcatheter aortic valve implantation and transcatheter edge-to-edge tricuspid valve repair for double valve dysfunction in a high-risk patient. Cureus, 2023, 15(9): e45648.
7. Salido Tahoces L, Sánchez Recalde A, Fernández-Golfín C, et al. Concomitant percutaneous treatment of aortic stenosis and tricuspid regurgitation. Eur Heart J Cardiovasc Imaging, 2022, 23(6): e262.
8. Taramasso M, Alessandrini H, Latib A, et al. Outcomes after current transcatheter tricuspid valve intervention: Mid-term results from the International TriValve Registry. JACC Cardiovasc Interv, 2019, 12(2): 155-165.
9. Hahn RT, Kodali S, Fam N, et al. Early multinational experience of transcatheter tricuspid valve replacement for treating severe tricuspid regurgitation. JACC Cardiovasc Interv, 2020, 13(21): 2482-2493.
10. Mahowald MK, Nishimura RA, Pislaru SV, et al. Reduction in right atrial pressures is associated with hemodynamic improvements after transcatheter edge-to-edge repair of the tricuspid valve. Circ Cardiovasc Interv, 2021, 14(12): e010557.
11. 陈思, 顾君君, 杨帆, 等. LuX-Valve系统经导管三尖瓣置换26例近期疗效分析. 中国心血管病研究, 2022, 20(2): 104-107.

Previous Article
Current epidemiology and trend of hypertension in Chinese adult

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Transcatheter valve implantation for aortic and tricuspid valve regurgitation: A case report

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Format

Content